ArticleMolecular cancer therapeutics2021

PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer.

Cheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.